StocksFundsScreenerSectorsWatchlists
AEHR

AEHR - Aehr Test Systems Stock Price, Fair Value and News

12.46USD+1.29 (+11.55%)Market Closed

Market Summary

AEHR
USD12.46+1.29
Market Closed
11.55%

AEHR Stock Price

View Fullscreen

AEHR RSI Chart

AEHR Valuation

Market Cap

359.5M

Price/Earnings (Trailing)

17.11

Price/Sales (Trailing)

4.41

EV/EBITDA

13.06

Price/Free Cashflow

56.18

AEHR Price/Sales (Trailing)

AEHR Profitability

Operating Margin

50.65%

EBT Margin

25.84%

Return on Equity

24.1%

Return on Assets

20.76%

Free Cashflow Yield

1.78%

AEHR Fundamentals

AEHR Revenue

Revenue (TTM)

81.5M

Rev. Growth (Yr)

44.66%

Rev. Growth (Qtr)

3.91%

AEHR Earnings

Earnings (TTM)

21.0M

Earnings Growth (Yr)

63.46%

Earnings Growth (Qtr)

30.27%

Breaking Down AEHR Revenue

Last 7 days

3.1%

Last 30 days

-17.1%

Last 90 days

-48.0%

Trailing 12 Months

-54.5%

How does AEHR drawdown profile look like?

AEHR Financial Health

Current Ratio

11.53

AEHR Investor Care

Shares Dilution (1Y)

3.93%

Diluted EPS (TTM)

0.71

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202363.0M65.0M74.9M81.5M
202238.2M50.8M55.9M61.1M
202112.7M16.6M20.2M28.2M
202025.8M22.3M18.8M13.6M
201921.1M21.1M21.8M22.8M
201829.0M29.6M27.3M25.3M
201713.8M18.9M20.6M24.3M
201614.7M14.5M13.2M12.8M
201513.6M10.0M13.1M15.1M
201417.6M19.7M19.5M17.2M
201317.9M16.5M15.4M15.3M
201214.6M15.5M16.2M17.4M
201113.2M13.7M15.7M16.0M
2010011.7M12.2M12.7M

Tracking the Latest Insider Buys and Sells of Aehr Test Systems

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 01, 2024
siu chris
sold (taxes)
-7,011
17.66
-397
cfo
Feb 06, 2024
posedel rhea j
acquired
70,740
3.93
18,000
-
Jan 29, 2024
engineer adil
sold (taxes)
-2,622
16.19
-162
chief operating officer
Jan 29, 2024
sporck alistair n
sold (taxes)
-2,444
16.19
-151
vp contactor business unit
Jan 29, 2024
rogers vernon
sold (taxes)
-2,574
16.19
-159
exec vp of sales & mktg.
Jan 29, 2024
ray-chaudhuri avijit k.
sold (taxes)
-1,619
16.19
-100
executive vp of r&d
Jan 29, 2024
erickson gayn
sold (taxes)
-8,839
16.19
-546
president and ceo
Jan 29, 2024
richmond donald p. ii
sold (taxes)
-1,878
16.19
-116
cto
Jan 18, 2024
erickson gayn
sold
-84,726
17.394
-4,871
president and ceo
Jan 18, 2024
richmond donald p. ii
sold
-17,759
17.394
-1,021
cto

1–10 of 50

Which funds bought or sold AEHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-1.83
-25,825
34,224
-%
Mar 15, 2024
B. Riley Wealth Advisors, Inc.
sold off
-100
-402,754
-
-%
Mar 11, 2024
VANGUARD GROUP INC
added
2.61
-27,168,800
40,027,400
-%
Mar 05, 2024
GREENWOOD CAPITAL ASSOCIATES LLC
added
121
247,349
1,116,700
0.07%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
sold off
-100
-78,284
-
-%
Mar 04, 2024
CONGRESS ASSET MANAGEMENT CO /MA
new
-
23,228,700
23,228,700
0.18%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
reduced
-91.46
-81,707,500
4,260,510
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
added
6.37
-225,715
364,363
-%
Feb 26, 2024
Virtu Financial LLC
new
-
537,000
537,000
0.04%
Feb 20, 2024
Able Wealth Management LLC
new
-
13,265
13,265
0.01%

1–10 of 39

Are Funds Buying or Selling AEHR?

Are funds buying AEHR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AEHR
No. of Funds

Unveiling Aehr Test Systems's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
5.24%
1,508,759
SC 13G
Feb 06, 2024
goldman sachs group inc
0.6%
187,005
SC 13G/A
Jan 26, 2024
blackrock inc.
7.2%
2,077,807
SC 13G
Apr 11, 2023
awm investment company, inc.
4.8%
1,328,713
SC 13G/A
Feb 14, 2023
collaborative holdings management lp
0%
0
SC 13G/A
Feb 14, 2023
awm investment company, inc.
5.9%
1,648,319
SC 13G
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 07, 2023
goldman sachs group inc
5.2%
1,446,690
SC 13G
Feb 14, 2022
collaborative holdings management lp
5.7%
1,533,440
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G

Recent SEC filings of Aehr Test Systems

View All Filings
Date Filed Form Type Document
Mar 01, 2024
4
Insider Trading
Feb 13, 2024
SC 13G
Major Ownership Report
Feb 07, 2024
4
Insider Trading
Feb 06, 2024
SC 13G/A
Major Ownership Report
Jan 31, 2024
4
Insider Trading
Jan 31, 2024
4
Insider Trading
Jan 31, 2024
4
Insider Trading
Jan 31, 2024
4
Insider Trading
Jan 31, 2024
4
Insider Trading
Jan 31, 2024
4
Insider Trading

What is the Fair Value of AEHR?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to Aehr Test Systems)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.3T
60.9B
29.85% 266.53%
75.82
37.04
125.85% 581.31%
290.2B
22.7B
3.32% 83.62%
339.79
12.79
-3.90% -35.30%
185.1B
54.2B
-2.16% 42.80%
109.57
3.41
-14.00% -78.92%
172.8B
26.5B
5.35% 71.49%
24.15
6.53
0.88% 10.98%
95.9B
11.6B
2.80% 4.12%
34.05
8.29
-8.03% -17.90%
MID-CAP
8.0B
6.5B
5.46% 23.23%
22.37
1.24
-8.30% -53.02%
5.0B
1.8B
0.66% -12.03%
28.17
2.77
-11.16% -46.12%
3.7B
1.1B
-3.53% -13.00%
14.9
3.25
22.89% 34.51%
3.2B
1.7B
0.34% -24.83%
14.23
1.95
-16.94% -31.42%
2.1B
258.2M
-6.99% -35.84%
-17.21
7.99
-25.06% -98.60%
SMALL-CAP
1.7B
557.7M
57.51% 159.16%
22.32
3.1
43.44% 97.00%
617.6M
640.0M
-3.44% -13.37%
-36.02
0.96
-19.44% -128.49%
359.5M
81.5M
-17.13% -54.54%
17.11
4.41
33.53% 70.08%
160.5M
550.0K
-14.53% 9.12%
-8.11
291.85
43.98% -13.47%
75.6M
116.7M
11.50% -47.44%
-3.94
0.65
15.07% -240.88%

Aehr Test Systems News

Latest updates
MarketBeat • 9 hours ago
Seeking Alpha • 25 Mar 2024 • 02:30 pm
InvestorPlace • 25 Mar 2024 • 11:36 am

Aehr Test Systems Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.9%21,43120,62422,26917,20614,81510,67120,28915,2839,6115,6467,6385,2671,6832,0123,7736,1116,8745,5337,2423,1635,911
Cost Of Revenue-1.6%10,47310,64310,7908,3316,9046,1909,8218,8865,0923,3654,1043,3731,3061,7853,8663,1203,6723,2623,8632,8913,513
Gross Profit9.8%10,9589,98111,4798,8757,9114,48110,4686,3974,5192,2813,5341,894377227-93.002,9913,2022,2713,3792722,398
Operating Expenses-6.4%5,4905,8665,8405,0824,4264,0234,6484,1413,8023,2742,9332,5462,3212,4142,7482,7362,9522,7003,2563,3882,963
  S&GA Expenses3.2%3,5183,4093,5873,2502,8752,5252,9932,6122,4891,9531,9041,6431,5011,5141,6741,8912,1571,8082,0181,8501,977
  R&D Expenses-19.7%1,9722,4572,2531,8321,5511,4981,6551,5291,3131,3211,0299038209008548457958921,120931986
EBITDA Margin4.0%0.29*0.28*0.25*0.25*0.22*0.18*0.19*0.12*0.06*-0.05*-0.11*-0.42*---------
Interest Expenses8.6%63158148737426312122.001.00-1.00-9.00-36.00-10.0012.0013.00-17.0013.002.0012.00-176-76.0074.00
Income Taxes25.0%20.0016.0011.0017.0018.0014.0010.0024.0034.0023.00-21534.004.00215-62.0014.006.006.006.00-2.0019.00
Earnings Before Taxes30.3%6,1094,6906,1224,1493,7436035,8042,267751719567-701-1,962-108-2,875259257-407116-3,203-610
EBT Margin3.5%0.26*0.25*0.23*0.23*0.20*0.17*0.19*0.11*0.05*-0.07*-0.13*-0.44*---------
Net Income30.3%6,0894,6746,1114,1323,7255895,7942,243717696567-735-1,966107-2,885245251-413110-3,201-629
Net Income Margin3.5%0.26*0.25*0.22*0.23*0.20*0.17*0.19*0.11*0.04*-0.07*-0.12*-0.43*---------
Free Cashflow-119.4%-7013,6174,684-1,202-2105,377-965-3,0223,2641,815-212-267---------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-4.1%101,175105,46998,14384,39667,54361,57862,32857,35558,18524,00121,66518,89117,11118,69120,57421,68824,30022,02521,30725,45129,901
  Current Assets-4.6%91,76596,21389,03076,58165,53559,32960,00755,27456,07721,69919,18416,36914,36815,97017,65118,48520,86718,29320,03424,22028,541
    Cash Equivalents-0.9%50,51450,95530,05417,18818,95436,22731,56432,10035,1116,6104,6624,8183,5296,3935,5135,1385,3825,3465,50812,30014,002
  Inventory7.2%33,81731,55723,90821,61917,97217,23315,05114,15213,03310,1468,8498,3399,0578,1027,9899,3309,8009,2179,0619,1899,983
  Net PPE3.3%3,1853,0832,7591,2811,2631,3221,2037766616766776176836226637838601,0001,0459751,074
Liabilities-44.6%14,02125,32422,54315,76210,87610,06011,33913,36717,3239,76910,2168,4066,3196,3706,5185,1338,3326,7395,85410,41012,017
  Current Liabilities-58.7%7,95919,25316,3089,38810,7469,89911,01412,81716,5458,7609,0616,9114,4834,1733,8653,3276,3444,5405,51210,01911,618
  Long Term Debt------------1874667461,026------
    LT Debt, Current-----------1,6791,4921,213933653----6,1106,110
    LT Debt, Non Current------------1874667461,026------
Shareholder's Equity8.7%87,15480,14575,60068,63456,66751,51850,98943,98840,86214,23211,44910,48510,79212,32114,05616,55515,96815,28615,45315,04117,884
  Retained Earnings12.8%-41,543-47,632-52,306-58,417-62,549-66,274-66,863-72,657-74,900-75,617-76,313-76,880-76,167-74,201-74,286-71,401-71,646-71,897-71,484-71,594-68,393
  Additional Paid-In Capital0.7%128,543127,630127,776126,930119,094117,668117,686116,507115,60289,66887,55387,17486,78686,35685,89885,53085,19484,76084,49984,17683,830
Shares Outstanding-100.0%-28,763-28,32027,73227,39527,12026,87126,83523,99923,45723,52523,322--------
Minority Interest----------------21.00-20.00-20.00-20.00-19.00-19.00-18.00
Float---------1*---34,124---38,434---36,888
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-114.0%-5453,9015,868-1,123-1955,461-767-2,9363,3371,874-190-256-2,898643-1,384-364-86.00-190-844-1,836-1,986
  Share Based Compensation22.2%638522653592793710820880718588303271257270299207205199200225224
Cashflow From Investing-100.9%-15617,7166,816-7,721-17,667-84.00-198-86.00-73.00-59.00-22.00-11.00-147-47.00-14.00-26.00-73.00-50.00-49.00-21.00-19.00
Cashflow From Financing136.6%254-6941847,242620-72436126.0025,23913577.001,5181751901,74913023162.00-5,986123203

AEHR Income Statement

2023-11-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Nov. 30, 2023
Nov. 30, 2022
Nov. 30, 2023
Nov. 30, 2022
Revenue:    
Total revenue$ 21,431$ 14,815$ 42,055$ 25,486
Cost of revenue:    
Total cost of revenue10,4736,90421,11613,094
Gross profit10,9587,91120,93912,392
Operating expenses:    
Research and development1,9721,5514,4293,049
Selling, general and administrative3,5182,8756,9275,400
Total operating expenses5,4904,42611,3568,449
Income from operations5,4683,4859,5833,943
Interest income, net6312631,212384
Other income (expense), net10(5)419
Income before provision for income taxes6,1093,74310,7994,346
Provision for income taxes20183632
Net income$ 6,089$ 3,725$ 10,763$ 4,314
Net income per share:    
Basic$ 0.21$ 0.14$ 0.37$ 0.16
Diluted$ 0.20$ 0.13$ 0.36$ 0.15
Shares used in per share calculations:    
Basic28,80127,57928,72527,410
Diluted29,76929,08029,70028,934
Product [Member]    
Revenue:    
Total revenue$ 19,837$ 14,007$ 39,194$ 23,595
Cost of revenue:    
Total cost of revenue9,7076,49719,62612,011
Services [Member]    
Revenue:    
Total revenue1,5948082,8611,891
Cost of revenue:    
Total cost of revenue$ 766$ 407$ 1,490$ 1,083

AEHR Balance Sheet

2023-11-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Nov. 30, 2023
May 31, 2023
Current assets:  
Cash and cash equivalents$ 50,514$ 30,054
Short-term investments017,853
Accounts receivable, net4,57316,594
Inventories33,81723,908
Prepaid expenses and other current assets2,861621
Total current assets91,76589,030
Property and equipment, net3,1852,759
Operating lease right-of-use assets, net5,9876,123
Other non-current assets238231
Total assets101,17598,143
Current liabilities:  
Accounts payable4,1839,206
Accrued expenses3,2324,143
Operating lease liabilities, short-term397137
Deferred revenue, short-term1472,822
Total current liabilities7,95916,308
Operating lease liabilities, long-term6,0166,163
Deferred revenue, long-term431
Other long-term liabilities4241
Total liabilities14,02122,543
Shareholders' equity:  
Preferred stock, $0.01 par value: Authorized: 10,000 shares Issued and outstanding: none00
Common stock, $0.01 par value: Authorized: 75,000 shares Issued and outstanding: 28,826 shares and 28,539 shares at November 30, 2023 and May 31, 2023, respectively288285
Additional paid-in-capital128,543127,776
Accumulated other comprehensive loss(134)(155)
Accumulated deficit(41,543)(52,306)
Total shareholders' equity87,15475,600
Total liabilities and shareholders' equity$ 101,175$ 98,143
AEHR
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.
 CEO
 WEBSITEwww.aehr.com
 EMPLOYEES104

Aehr Test Systems Frequently Asked Questions


What is the ticker symbol for Aehr Test Systems? What does AEHR stand for in stocks?

AEHR is the stock ticker symbol of Aehr Test Systems. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aehr Test Systems (AEHR)?

As of Wed Mar 27 2024, market cap of Aehr Test Systems is 359.46 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AEHR stock?

You can check AEHR's fair value in chart for subscribers.

What is the fair value of AEHR stock?

You can check AEHR's fair value in chart for subscribers. The fair value of Aehr Test Systems is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aehr Test Systems is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AEHR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aehr Test Systems a good stock to buy?

The fair value guage provides a quick view whether AEHR is over valued or under valued. Whether Aehr Test Systems is cheap or expensive depends on the assumptions which impact Aehr Test Systems's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AEHR.

What is Aehr Test Systems's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, AEHR's PE ratio (Price to Earnings) is 17.11 and Price to Sales (PS) ratio is 4.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AEHR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Aehr Test Systems's stock?

In the past 10 years, Aehr Test Systems has provided 0.174 (multiply by 100 for percentage) rate of return.